Literature DB >> 7633733

The effect of posture on airway caliber with the sleep-apnea/hypopnea syndrome.

S E Martin1, I Marshall, N J Douglas.   

Abstract

Snoring and sleep apnea are more common in the supine than seated position. We therefore studied the effect of posture on upper-airway caliber in normal subjects, snorers, and subjects with the sleep-apnea/hypopnea syndrome (SAHS). We measured upper-airway cross-sectional area by acoustic reflection in 110 SAHS patients (apnea/hypopnea index [AHI] > 15), 70 snorers without SAHS (AHI < 15), and 40 male controls matched for body-mass index (BMI) to the 40 SAHS patients. SAHS patients in the seated position had smaller upper-airway areas at the orophyngeal junction (OPJ) than either the snorers (p < 0.01) or the normal subjects (p < 0.02), but there were no differences between groups in airway cross-sectional areas in the supine or lateral recumbent positions. SAHS patients had significantly smaller decreases in OPJ area from the seated to either the supine (p < 0.001) or lateral recumbent (p < 0.001) positions than did the snorers. SAHS patients also had smaller (p < 0.05) decreases in OPJ area upon lying down than did the BMI-matched normal subjects. These data are compatible with SAHS patients defending their upper airway more upon lying down than do snorers or normal subjects.

Entities:  

Mesh:

Year:  1995        PMID: 7633733     DOI: 10.1164/ajrccm.152.2.7633733

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  21 in total

1.  Effect of laser-assisted uvulopalatoplasty on oral airway resistance during wakefulness in obstructive sleep apnea syndrome.

Authors:  Ching-Chi Lin; Kuo-Sheng Lee; Ke-Chang Chang; Kun-Ming Wu; Chon-Shin Chou
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-09-15       Impact factor: 2.503

2.  Elevated posture for the management of obstructive sleep apnea.

Authors:  Margot A Skinner; Ruth N Kingshott; David R Jones; Sean D R Homan; D Robin Taylor
Journal:  Sleep Breath       Date:  2004-12       Impact factor: 2.816

3.  Negative Expiratory Pressure Technique: An Awake Test to Measure Upper Airway Collapsibility in Adolescents.

Authors:  Helena Larramona Carrera; Carole L Marcus; Joseph M McDonough; Joan C Oliva Morera; Jingtao Huang; Ramon Farre; Josep M Montserrat
Journal:  Sleep       Date:  2015-11-01       Impact factor: 5.849

4.  Heritability of upper airway dimensions derived using acoustic pharyngometry.

Authors:  S R Patel; J M Frame; E K Larkin; S Redline
Journal:  Eur Respir J       Date:  2008-06-25       Impact factor: 16.671

Review 5.  Respiratory dreams and nightmares.

Authors:  N Douglas
Journal:  Thorax       Date:  1996-09       Impact factor: 9.139

6.  The role of upper airway morphology in apnea versus hypopnea predominant obstructive sleep apnea patients: an exploratory study.

Authors:  Jintao Xu
Journal:  Br J Radiol       Date:  2018-06-05       Impact factor: 3.039

7.  Predictive value of Kushida index and acoustic pharyngometry for the evaluation of upper airway in subjects with or without obstructive sleep apnea.

Authors:  Dae Gun Jung; Hae Young Cho; Ronald R Grunstein; Brendon Yee
Journal:  J Korean Med Sci       Date:  2004-10       Impact factor: 2.153

8.  The efficacy of a mandibular advancement splint in relation to cephalometric variables.

Authors:  Margot A Skinner; Christopher J Robertson; Ruth N Kingshott; David R Jones; D Robin Taylor
Journal:  Sleep Breath       Date:  2002-09       Impact factor: 2.816

Review 9.  Acoustic reflection: review and clinical applications for sleep-disordered breathing.

Authors:  John S Viviano
Journal:  Sleep Breath       Date:  2002-09       Impact factor: 2.816

10.  Acoustic pharyngometry measurement of minimal cross-sectional airway area is a significant independent predictor of moderate-to-severe obstructive sleep apnea.

Authors:  Pamela N Deyoung; Jessie P Bakker; Scott A Sands; Salma Batool-Anwar; James G Connolly; James P Butler; Atul Malhotra
Journal:  J Clin Sleep Med       Date:  2013-11-15       Impact factor: 4.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.